Oshrat Levi
@Sphera Funds Management Ltd.
Latest period2024 - Q3ReportedManaged Assets$628.383MTotal holdings109
Assets growth rate-14.3%Assets growth rate (2-Q avg)-5.64%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Sphera Funds Management Ltd.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 109 positions.
Assets under management
The assets under management (AUM) of Sphera Funds Management Ltd. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 628.383M in assets, with a quarterly growth rate of -14.3% and a 2-quarter average growth rate of -5.64%. The portfolio is managed by Oshrat Levi, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
NVMINova Ltd
| 1.73% | $10.825M 51,960 shares@ $208.34 avg price | New Position |
VKTXViking Therapeutics Inc
| 1.35% | $8.424M 133,066 shares@ $63.31 avg price | New Position |
CYBNCybin Inc
| 1.33% | $8.296M 933,225 shares@ $8.9 avg price | New Position |
CHKPCheck Point Software Tech Lt
| 1.24% | $7.754M 40,215 shares@ $192.81 avg price | New Position |
BHVNBiohaven Ltd
| 1.07% | $6.662M 133,323 shares@ $49.97 avg price | New Position |
APLSApellis Pharmaceuticals Inc
| 1% | $6.226M 215,873 shares@ $28.84 avg price | New Position |
6866⤦Ormat Technologies Inc
| 0.84% | $5.255M 5.037M shares@ $1.05 avg price | New Position |
CGEMCullinan Therapeutics Inc
| 0.5% | $3.111M 185,871 shares@ $16.75 avg price | New Position |
CRWDCrowdstrike Hldgs Inc
| 0.49% | $3.046M 10,862 shares@ $280.47 avg price | New Position |
ZURAZura Bio Ltd
| 0.48% | $2.999M 738,718 shares@ $4.06 avg price | New Position |